Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Jin Yang Pharmaceutical Revenue

Jin Yang Pharmaceutical had revenue of 32.40B KRW in the quarter ending March 31, 2026, with 4.72% growth. This brings the company's revenue in the last twelve months to 122.15B, up 4.53% year-over-year. In the year 2025, Jin Yang Pharmaceutical had annual revenue of 120.69B with 6.49% growth.

• Revenue (ttm): 122.15B
• Revenue Growth: +4.53%
• P/S Ratio: 0.45
• Revenue / Employee: 555.21M
• Employees: 220
• Market Cap: 55.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	120.69B	7.35B	6.49%
Dec 31, 2024	113.33B	19.62B	20.94%
Dec 31, 2023	93.71B	17.44B	22.87%
Dec 31, 2022	76.26B	13.43B	21.36%
Dec 31, 2021	62.84B	13.31B	26.88%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error